Compare Recursion Pharmaceuticals Inc (RXRX) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Recursion Pharmaceuticals Inc vs Tenet Healthcare Corporation — how do they compare? Recursion Pharmaceuticals Inc trades at $3.08 (market cap $1.53B), while Tenet Healthcare Corporation trades at $196.03 (market cap $16.74B). The key difference: Tenet Healthcare Corporation is far larger — about 10.9× Recursion Pharmaceuticals Inc's market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, Recursion Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| RXRX | THC | |
|---|---|---|
Market Cap | $1.53B | $16.74B |
Sector | Health | Health |
52-Week High | $6.79 | $244.80 |
52-Week Low | $2.84 | $148.38 |
Enterprise Value | $946.50M | $26.99B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
